TrialThe New England journal of medicine2018

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.

Ghassan K Abou-Alfa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.